Bachem Holding AG Stock Swiss Exchange
Stocks
BANB
CH0012530207
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 5.78B 7.14B 6.14B 5.28B 9.87B 674B 9.9B 68.27B 26.49B 346B 26.8B 26.21B 1,114B | P/E 2026 * |
31.7x | P/E 2027 * | 24.6x |
|---|---|---|---|---|---|
| Enterprise Value | 6.16B 7.61B 6.55B 5.63B 10.53B 719B 10.56B 72.82B 28.26B 369B 28.58B 27.96B 1,188B | EV / Sales 2026 * |
6.54x | EV / Sales 2027 * | 5.49x |
| Free-Float |
99.67% | Yield 2026 * |
1.31% | Yield 2027 * | 1.48% |
Last Transcript : Bachem Holding AG
| 1 day | -1.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 2025-12-31 | |
Alain Schaffter
DFI | Director of Finance/CFO | 49 | 2021-01-31 |
Hans Van Hees
COO | Chief Operating Officer | - | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2011-04-12 | |
Kuno Sommer
CHM | Chairman | 70 | 2012-04-24 |
Helma Wennemers
BRD | Director/Board Member | 57 | 2014-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.43% | +7.92% | - | - | 7.14B | |
| -2.54% | -2.84% | -1.77% | +14.72% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +523.39% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +21.22% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +74.90% | 40.73B | |
| +0.53% | -1.36% | +16.87% | +47.12% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +123.04% | 16.5B | |
| -1.01% | +0.50% | +13.91% | +31.45% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.22% | 13.77B | |
| Average | -0.97% | +0.53% | +74.05% | +109.63% | 30.55B | |
| Weighted average by Cap. | -1.04% | +0.11% | +89.42% | +127.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 942M 1.16B 1B 861M 1.61B 110B 1.61B 11.13B 4.32B 56.37B 4.37B 4.27B 182B | 1.17B 1.44B 1.24B 1.07B 1.99B 136B 2B 13.78B 5.35B 69.78B 5.41B 5.29B 225B |
| Net income | 183M 226M 195M 167M 313M 21.35B 314M 2.16B 839M 10.95B 849M 831M 35.28B | 232M 286M 246M 211M 396M 27B 397M 2.74B 1.06B 13.85B 1.07B 1.05B 44.63B |
| Net Debt | 385M 475M 409M 351M 657M 44.85B 659M 4.54B 1.76B 23.01B 1.78B 1.74B 74.14B | 628M 776M 668M 574M 1.07B 73.26B 1.08B 7.42B 2.88B 37.59B 2.91B 2.85B 121B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
